Ironwood Pharmaceuticals, Inc. (IRWD)
Largest Insider Buys in Sector
IRWD Stock Price History Chart
IRWD Stock Performance
About Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
Insider Activity of Ironwood Pharmaceuticals, Inc.
Over the last 12 months, insiders at Ironwood Pharmaceuticals, Inc. have bought $460,539 and sold $5.97M worth of Ironwood Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Ironwood Pharmaceuticals, Inc. have bought $11.71M and sold $5.14M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Emany Sravan Kumar (SVP, Chief Financial Officer) — $400,335. Duane Jon R (director) — $60,204.
The last purchase of 6,920 shares for transaction amount of $60,204 was made by Duane Jon R (director) on 2024‑03‑06.
List of Insider Buy and Sell Transactions, Ironwood Pharmaceuticals, Inc.
| 2024-06-10 | Sale | McHugh Julie | director | 22,766 0.0138% | $6.29 | $143,198 | -7.72% | |
| 2024-06-07 | Sale | Moukheibir Catherine | director | 35,574 0.0233% | $6.61 | $235,144 | -4.09% | |
| 2024-06-06 | Sale | Moukheibir Catherine | director | 44,426 0.0276% | $6.36 | $282,549 | -4.96% | |
| 2024-05-20 | Sale | MCCOURT Thomas A | Chief Executive Officer | 67,618 0.0427% | $6.45 | $436,136 | -3.27% | |
| 2024-05-20 | Sale | Shetzline Michael | CMO,SVP,Head-Res&Drug | 16,128 0.0102% | $6.45 | $104,026 | -3.27% | |
| 2024-05-20 | Sale | John Minardo | Chief Legal Officer | 17,404 0.011% | $6.45 | $112,256 | -3.27% | |
| 2024-05-20 | Sale | Davis Andrew | SVP, Chief Business Officer | 22,725 0.0144% | $6.45 | $146,576 | -3.27% | |
| 2024-03-06 | Duane Jon R | director | 6,920 0.0045% | $8.70 | $60,204 | -8.58% | ||
| 2024-03-04 | Emany Sravan Kumar | SVP, Chief Financial Officer | 10,684 0.0069% | $9.38 | $100,216 | -15.40% | ||
| 2024-02-12 | Sale | MCCOURT Thomas A | Chief Executive Officer | 177,164 0.1118% | $15.24 | $2.7M | -47.50% | |
| 2024-02-12 | Sale | Shetzline Michael | CMO,SVP,Head-Res&Drug | 38,618 0.0244% | $15.24 | $588,538 | -47.50% | |
| 2024-02-12 | Sale | John Minardo | Chief Legal Officer | 47,380 0.0299% | $15.24 | $722,071 | -47.50% | |
| 2024-02-12 | Sale | Davis Andrew | SVP, Chief Business Officer | 9,846 0.0062% | $15.24 | $150,053 | -47.50% | |
| 2024-02-12 | Sale | Silver Ronald | Principal Accounting Officer | 7,908 0.005% | $15.24 | $120,518 | -47.50% | |
| 2023-12-14 | Sale | Kessler Marla L | director | 9,926 0.0062% | $11.19 | $111,072 | -24.64% | |
| 2023-11-20 | Sale | Davis Andrew | SVP, Chief Business Officer | 3,287 0.0022% | $9.69 | $31,851 | -4.29% | |
| 2023-09-15 | Emany Sravan Kumar | SVP, Chief Financial Officer | 36,072 0.0231% | $8.32 | $300,119 | +11.63% | ||
| 2023-08-14 | Sale | John Minardo | Chief Legal Officer | 7,045 0.0045% | $10.04 | $70,732 | -7.58% | |
| 2023-08-14 | Sale | Silver Ronald | Principal Accounting Officer | 1,976 0.0013% | $10.04 | $19,839 | -7.58% | |
| 2023-05-30 | Sale | MCCOURT Thomas A | Chief Executive Officer | 26,632 0.0172% | $10.70 | $284,962 | -10.23% |
Insider Historical Profitability
| MCCOURT Thomas A | Chief Executive Officer | 1150330 0.4857% | $6.18 | 0 | 33 | |
| Shetzline Michael | CMO,SVP,Head-Res&Drug | 413719 0.2057% | $6.18 | 0 | 10 | |
| Davis Andrew | SVP, Chief Business Officer | 288031 0.1392% | $6.18 | 0 | 7 | |
| John Minardo | Chief Legal Officer | 294571 0.1231% | $6.18 | 0 | 6 | |
| Emany Sravan Kumar | SVP, Chief Financial Officer | 301733 0.1209% | $6.18 | 2 | 1 | |
| Silver Ronald | Principal Accounting Officer | 134264 0.0859% | $6.18 | 0 | 11 | |
| Duane Jon R | director | 121028 0.0773% | $6.18 | 1 | 0 | |
| McHugh Julie | 139528 0.0758% | $6.18 | 0 | 12 | ||
| Kessler Marla L | director | 96572 0.0619% | $6.18 | 0 | 2 | |
| Moukheibir Catherine | director | 48633 0.0306% | $6.18 | 0 | 2 | |
| DENNER ALEXANDER J | 16390000 10.4977% | $6.18 | 8 | 0 | +18.72% | |
| Ridgeback Capital Investments L.P. | 10 percent owner | 6842839 4.3828% | $6.18 | 3 | 42 | <0.0001% |
| Hecht Peter M | Chief Executive Officer | 4696917 3.0084% | $6.18 | 1 | 16 | +9.03% |
| FMR LLC | 10 percent owner | 837736 0.5366% | $6.18 | 0 | 43 | |
| Currie Mark G | 521758 0.3342% | $6.18 | 0 | 37 | ||
| Mallon Mark | Chief Executive Officer | 470605 0.3014% | $6.18 | 0 | 4 | |
| Consylman Gina | SVP, CFO & Treasurer | 336244 0.2154% | $6.18 | 0 | 17 | |
| Rickard Jason | SVP, Chief Operating Officer | 332648 0.2131% | $6.18 | 0 | 15 | |
| Higgins Michael J | Chief Operating Officer | 300000 0.1921% | $6.18 | 0 | 7 | |
| Gilbert Halley E | Chief Admin Officer & SVP | 265991 0.1704% | $6.18 | 0 | 14 | |
| Owens Edward P | director | 218954 0.1402% | $6.18 | 4 | 0 | +34.25% |
| Kilroy Conor | SVP, GC & Secretary | 122336 0.0784% | $6.18 | 0 | 3 | |
| MacDonald Kelly | Chief Accounting Officer | 93041 0.0596% | $6.18 | 0 | 9 | |
| OLANOFF LAWRENCE S | director | 68629 0.044% | $6.18 | 0 | 17 | |
| COOK JOSEPH C JR | director | 42775 0.0274% | $6.18 | 0 | 6 | |
| Graney Thomas | Chief Financial Officer | 20763 0.0133% | $6.18 | 0 | 2 | |
| Fanucci Marsha | director | 19778 0.0127% | $6.18 | 1 | 1 | |
| ROBERTS BRYAN E | director | 0 0% | $6.18 | 0 | 13 | |
| MCGUIRE TERRANCE | director | 0 0% | $6.18 | 0 | 1 |
Institutional Investor Ownership
| BlackRock | $210.41M | 15.2 | 24.16M | -7.01% | -$15.87M | 0.01 | |
| The Vanguard Group | $170.03M | 12.28 | 19.52M | +21.75% | +$30.38M | <0.01 | |
| Sarissa Capital Management LP | $142.76M | 10.31 | 16.39M | 0% | +$0 | 24.97 | |
| State Street | $121.22M | 8.76 | 13.92M | +20.68% | +$20.77M | 0.01 | |
| Pacer Advisors Inc | $62.77M | 4.53 | 7.21M | New | +$62.77M | 0.16 | |
| Renaissance Technologies | $61.84M | 4.47 | 7.1M | +7.64% | +$4.39M | 0.1 | |
| LSV Asset Management | $53.58M | 3.87 | 6.15M | -9.3% | -$5.5M | 0.11 | |
| Armistice Capital Llc | $47.03M | 3.4 | 5.4M | -5.26% | -$2.61M | 0.56 | |
| Jacobs Levy Equity Management | $36.89M | 2.67 | 4.24M | +40.75% | +$10.68M | 0.17 | |
| Braidwell Lp | $30.4M | 2.2 | 3.49M | New | +$30.4M | 1.71 | |
| Geode Capital Management | $27.42M | 1.98 | 3.15M | +2.17% | +$580,990.61 | <0.01 | |
| UBS | $26.37M | 1.91 | 3.03M | +579.91% | +$22.49M | 0.01 | |
| Man Group Plc | $26M | 1.88 | 2.99M | +109.44% | +$13.59M | 0.06 | |
| Brown Capital Management | $23.52M | 1.7 | 2.7M | -27.19% | -$8.79M | 0.42 | |
| Morgan Stanley | $23.33M | 1.69 | 2.68M | +24.69% | +$4.62M | <0.01 | |
| Nuveen | $16.05M | 1.16 | 1.84M | +0.38% | +$60,255.78 | 0.01 | |
| Kynam Capital Management Lp | $14.15M | 1.02 | 1.63M | New | +$14.15M | 0.18 | |
| Northern Trust | $13.35M | 0.96 | 1.53M | -3.52% | -$486,671.21 | <0.01 | |
| Deutsche Bank | $13.22M | 0.96 | 1.52M | +234.5% | +$9.27M | 0.01 | |
| Jupiter Fund Management | $12.89M | 0.93 | 1.48M | -34.8% | -$6.88M | 0.04 | |
| Charles Schwab | $12.13M | 0.88 | 1.39M | +8.05% | +$903,662.49 | <0.01 | |
| Glenmede | $12.11M | 0.88 | 1.39M | +7.6% | +$855,313.28 | 0.06 | |
| Goldman Sachs | $12.02M | 0.87 | 1.38M | +27.55% | +$2.6M | <0.01 | |
| Schonfeld Group | $11.43M | 0.83 | 1.31M | +1,698.19% | +$10.79M | 0.08 | |
| Two Sigma Advisers LP | $11.19M | 0.81 | 1.28M | -4.23% | -$494,728.00 | 0.02 | |
| Two Sigma | $10.35M | 0.75 | 1.19M | +102.82% | +$5.25M | 0.02 | |
| JPMorgan Chase | $10.32M | 0.75 | 1.19M | -18.54% | -$2.35M | <0.01 | |
| BNY Mellon | $9.04M | 0.65 | 1.04M | -8.03% | -$789,126.02 | <0.01 | |
| Rafferty Asset Management Llc | $8.87M | 0.64 | 1.02M | +45.04% | +$2.75M | 0.03 | |
| First Eagle Investment Management | $8.73M | 0.63 | 1M | +10.47% | +$827,450.02 | 0.02 | |
| Citigroup | $8.25M | 0.6 | 947,710 | +161.8% | +$5.1M | 0.01 | |
| Saturn V Capital Management Llc | $8.23M | 0.59 | 944,912 | New | +$8.23M | 3.3 | |
| Bank of America | $7.89M | 0.57 | 906,289 | +31.96% | +$1.91M | <0.01 | |
| Hodges Capital | $7.52M | 0.54 | 863,500 | New | +$7.52M | 0.49 | |
| Parkman Healthcare Partners Llc | $7.4M | 0.54 | 850,000 | +604.51% | +$6.35M | 0.91 | |
| Citadel Advisors LLC | $7.26M | 0.52 | 833,274 | +68.18% | +$2.94M | 0.01 | |
| Emerald Advisers, Inc. | $7.17M | 0.52 | 822,749 | New | +$7.17M | 0.29 | |
| New York State Common Retirement Fund | $7.05M | 0.51 | 809,002 | +2.18% | +$150,378.17 | 0.01 | |
| Russell Investments Group Ltd | $6.78M | 0.49 | 777,847 | +244.76% | +$4.81M | 0.01 | |
| EMERALD MUTUAL FUND ADVISERS TRUST | $5.61M | 0.41 | 644,153 | New | +$5.61M | 0.3 | |
| Ameriprise Financial | $5.33M | 0.39 | 612,407 | -22.19% | -$1.52M | <0.01 | |
| ROYCE & ASSOCIATES INC | $5.15M | 0.37 | 591,004 | +97.82% | +$2.55M | 0.05 | |
| Marshall Wace | $4.99M | 0.36 | 572,500 | +98.91% | +$2.48M | 0.01 | |
| Invesco | $4.5M | 0.33 | 516,963 | -7.36% | -$357,667.46 | <0.01 | |
| AQR Capital | $4.09M | 0.3 | 469,742 | +474.25% | +$3.38M | 0.01 | |
| Millennium Management LLC | $4.02M | 0.29 | 461,444 | -52.53% | -$4.45M | <0.01 | |
| 13D Management LLC | $3.65M | 0.26 | 419,284 | +14.04% | +$449,740.77 | 2.23 | |
| Legal & General | $3.45M | 0.25 | 396,607 | +0.86% | +$29,431.10 | <0.01 | |
| Redwood Investment Management, LLC | $3.19M | 0.23 | 366,691 | +29.75% | +$732,294.95 | 0.37 | |
| RhumbLine Advisers | $3.16M | 0.23 | 363,124 | -20.84% | -$832,835.16 | <0.01 |